Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies-Reference-Cited by-同舟云学术

Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies

Published:2024-03 Issue: Volume:182 Page:63-69
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Recio Fernando,Scalise Carly Bess,Loar Paul,Lumish Melissa,Berman Tara,Peddada Abhinand,Kalashnikova Ekaterina,Rivero-Hinojosa Samuel,Beisch Tricia,Nicosia Brittany,Farmer Tiffany,Dutta Punashi,Malhotra Meenakshi,ElNaggar Adam C.,Liu Minetta C.,Vaccarello Luis,Holloway Robert W.

Publisher

Elsevier BV

Reference36 articles.

1. Endometrial cancer;Crosbie;Lancet,2022

2. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

3. “Endometrial Cancer,” in StatPearls. Treasure Island (FL);Mahdy,2023

4. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019;Gu;Gynecol. Oncol.,2021

5. Molecular classification and emerging targeted therapy in endometrial Cancer;Yen;Int. J. Gynecol. Pathol.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of post-operative ctDNA detection with outcomes of patients with early breast cancers;ESMO Open;2024-09

2. Translating biological insights into improved management of endometrial cancer;Nature Reviews Clinical Oncology;2024-08-28

3. Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer;Gynecologic Oncology Reports;2024-08

4. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients;International Review of Cell and Molecular Biology;2024